June 24 (Reuters) - Lexeo Therapeutics Inc LXEO.O:
LEXEO THERAPEUTICS, PERCEPTIVE XONTOGENY VENTURE FUNDS AND VENBIO PARTNERS ANNOUNCE PARTNERSHIP TO ADVANCE NOVEL CARDIAC RNA THERAPEUTICS
LEXEO THERAPEUTICS INC: INVESTMENT OF UP TO $40 MILLION FROM PERCEPTIVE XONTOGENY VENTURE FUNDS AND VENBIO PARTNERS
Source text: ID:nGNX8td1pG
Further company coverage: LXEO.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.